A Randomized Controlled Trial of VSL#3 for the Prevention of Endoscopic Recurrence Following Surgery for Crohn's Disease.

PHASE3CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

December 31, 2003

Conditions
Crohn's DiseaseInflammatory Bowel Disease
Interventions
DRUG

Probiotic - VSL#3

Trial Locations (17)

Unknown

Health Sciences Centre, Calgary

Royal Alexandra Hospital, Edmonton

Walter Mackenzie Health Sciences Centre, Edmonton

St. Paul's Hospital, Vancouver

Dr. D.M. Petrunia, Inc., Victoria

Health Sciences Centre, Winnipeg

Queen Elizabeth II Health Sciences Centre, Halifax

Surrey GI Clinic, Guelph

McMaster University Medical Centre, Hamilton

Hotel-Dieu Hospital, Kingston

London Health Sciences Centre, London

Ottawa Hospital - Civic Campus, Ottawa

Mount Sinai Hospital, Toronto

Hopital Maisonneuve-Rosemont, Montreal

Hospitalier de l'Universite de Montreal, Montreal

Royal Victoria Hospital, Montreal

Hopital St-Sacrement, Québec

All Listed Sponsors
collaborator

Canadian Institutes of Health Research (CIHR)

OTHER_GOV

lead

University of Alberta

OTHER

NCT00175292 - A Randomized Controlled Trial of VSL#3 for the Prevention of Endoscopic Recurrence Following Surgery for Crohn's Disease. | Biotech Hunter | Biotech Hunter